Artificial Intelligence Gains Ground Across Healthcare

The potential for Artificial Intelligence (AI) is extensive and its adoption across the healthcare industry is accelerating. But in pharma, legacy systems, insufficient storage capacity, and poor interoperability might hold them back from leveraging its benefits during new product clinical development.

As company decision makers see more ways to leverage AI, it’s likely more pharmaceutical developers will look at what they need to do to make AI a reality.

In this article, industry leaders, including ERT’s Dave Coman and Don Ragas, present examples of how pharma can take the first step in adoping AI to improve efficiencies and increase patient engagement during clinical trials.


Share